Breaking barriers in rare disease drug development
Bringing rare disease treatments from pipeline to patient Rare diseases affect more than 395 million people worldwide, yet only 5% have an FDA-approved treatment. The challenges of small patient populations, regulatory complexities, and limited clinical data have historically slowed progress. But the landscape is changing. This infographic explores the key barriers in rare disease drug […]
Unstructured EMR data expands cohort identification by 1,500%
By using integrated EMR, lab and claims data, Panalgo was able to provide the manufacturer with a rich longitudinal history for all identified patients.
Powering unbiased outcomes research with longitudinal data
The Panalgo team linked its unstructured EMR data, powered by NorstellaLinQ, to its closed claims data for a comprehensive, unbiased analysis. Within eight weeks, the client had access to years of longitudinal arthroplasty data, representing both inpatient and outpatient procedures, to fuel its study.